Neurostimulation Devices Market Size, Share, Growth Analysis, By Type(Implantable Devices and Non-Implantable Devices), By Application(Pain Management and Parkinson's Disease), By Region(North America, Europe, Asia Pacific, Middle East and Africa), By Region - Industry Forecast 2024-2031

North America secures the top spot when it comes to global neurostimulation device demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and availability of favorable reimbursement for neurological procedures are helping this region maintain a high market share. The increasing geriatric population and high investments in neurological research are also expected to create new opportunities for suppliers of neurostimulation devices in this region. The United States and Canada are slated to be the top markets in North America for neurostimulation device providers going forward. Moreover, the presence of key medical device manufacturers in this region will also aid the dominance of North America going forward.

Asia-Pacific is expected to emerge as the fastest-expanding regional market for neurostimulation device companies in the world. Growing healthcare expenditure, rising awareness regarding neurological disorders, and a rapidly expanding senescent population base in countries such as Japan and China are providing lucrative opportunities for neurostimulation device companies in this region. Rising disposable income of people and their willingness to opt for novel treatments and therapies will also play a crucial role in promoting sales of neurostimulation devices in the Asia Pacific region. India is also expected to be a highly opportune market for neurostimulation device providers going forward.